MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
76
Web
https://mineralystx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.38B
P/E Ratio
N/A
Total Cash
646.06M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.58
Dividend Yield
N/A
Total Cash/Share
7.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MLYS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MLYS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
76
Web
https://mineralystx.com